Sona Nanotech Inc.

CNSX:SONA Stock Report

Market Cap: CA$29.0m

Sona Nanotech Management

Management criteria checks 3/4

Sona Nanotech's CEO is David Regan, appointed in Jul 2020, has a tenure of 4.5 years. total yearly compensation is CA$405.47K, comprised of 64.1% salary and 35.9% bonuses, including company stock and options. directly owns 0.47% of the company’s shares, worth CA$136.50K. The average tenure of the management team and the board of directors is 3.2 years and 3 years respectively.

Key information

David Regan

Chief executive officer

CA$405.5k

Total compensation

CEO salary percentage64.1%
CEO tenure4.5yrs
CEO ownership0.5%
Management average tenure3.2yrs
Board average tenure3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Regan's remuneration changed compared to Sona Nanotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 31 2024n/an/a

-CA$3m

Apr 30 2024n/an/a

-CA$3m

Jan 31 2024n/an/a

-CA$3m

Oct 31 2023CA$405kCA$260k

-CA$2m

Jul 31 2023n/an/a

-CA$847k

Apr 30 2023n/an/a

-CA$796k

Jan 31 2023n/an/a

-CA$2m

Oct 31 2022CA$420kCA$260k

-CA$2m

Jul 31 2022n/an/a

-CA$5m

Apr 30 2022n/an/a

-CA$6m

Jan 31 2022n/an/a

-CA$8m

Oct 31 2021CA$260kCA$260k

-CA$10m

Jul 31 2021n/an/a

-CA$12m

Apr 30 2021n/an/a

-CA$12m

Jan 31 2021n/an/a

-CA$10m

Oct 31 2020CA$3mCA$66k

-CA$6m

Compensation vs Market: David's total compensation ($USD282.88K) is above average for companies of similar size in the Canadian market ($USD166.13K).

Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.

CEO

David Regan (55 yo)

4.5yrs

Tenure

CA$405,472

Compensation

Mr. David Andrew Regan served as Independent Director at Olive Resource Capital Inc. (formerly known as Norvista Capital Corporation) since November 21, 2019 until September 25, 2024. He serves as the Pres...

Leadership Team

NamePositionTenureCompensationOwnership
David Regan
Chief Executive Officer4.5yrsCA$405.47k0.47%
CA$ 136.5k
Robert William Randall
CFO & Corporate Secretary7.2yrsCA$90.08k0.48%
CA$ 138.5k
Len Pagliaro
CSO & Director1.8yrsCA$230.08k9.12%
CA$ 2.6m
Kulbir Singh
Co-Founder & Head of R&Dno datano datano data
Mike McAlduff
Director of R&D & Production and Founder11yrsno datano data
Gerrard Marangoni
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Darren Rowles
Head of Diagnostics1.8yrsCA$189.00kno data
Carman Giacomantonio
Chief Medical Officerless than a yearno data0.61%
CA$ 177.3k

3.2yrs

Average Tenure

55yo

Average Age

Experienced Management: SONA's management team is considered experienced (3.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Len Pagliaro
CSO & Director1.7yrsCA$230.08k9.12%
CA$ 2.6m
Gerrard Marangoni
Co-Founder & Member of Scientific Advisory Board5.2yrsno datano data
John Lievonen
Independent Chairman4.2yrsCA$61.50k0.022%
CA$ 6.5k
Neil Fraser
Independent Director3yrsCA$32.89k0.22%
CA$ 65.0k
Harold Megann
Director5.1yrsCA$27.17k3.88%
CA$ 1.1m
Walter Strapps
Independent Director3yrsCA$27.17kno data
Wayne Myles
Directorless than a yearno datano data
Catherine Murphy
Member of Scientific Advisory Boardno datano datano data
Fiona Marshall
Member of Scientific Advisory Boardno datano datano data
Swarna Balasubramaniam
Member of Advisory Boardno datano datano data

3.0yrs

Average Tenure

Experienced Board: SONA's board of directors are considered experienced (3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 17:35
End of Day Share Price 2025/01/06 00:00
Earnings2024/07/31
Annual Earnings2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sona Nanotech Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution